0001140361-20-025497.txt : 20201113 0001140361-20-025497.hdr.sgml : 20201113 20201113160625 ACCESSION NUMBER: 0001140361-20-025497 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHP Merger Corp. CENTRAL INDEX KEY: 0001785041 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 842590924 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39140 FILM NUMBER: 201311499 BUSINESS ADDRESS: STREET 1: C/O CHP MERGER CORP. STREET 2: 25 DEFOREST AVENUE, SUITE 108 CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 212-508-7090 MAIL ADDRESS: STREET 1: C/O CHP MERGER CORP. STREET 2: 25 DEFOREST AVENUE, SUITE 108 CITY: SUMMIT STATE: NJ ZIP: 07901 10-Q 1 brhc10016734_10q.htm 10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to

Commission File No. 001-39140

CHP MERGER CORP.
(Exact name of registrant as specified in its charter)

Delaware
 
84-290924
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

25 Deforest Avenue, Suite 108
Summit, New Jersey 07901
(Address of Principal Executive Offices, including zip code)

(212) 508-7090
(Registrant’s telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant

CHPMU

The Nasdaq Stock Market LLC
Redeemable common stock included as part of the units

CHPM

The Nasdaq Stock Market LLC
Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50

CHPMW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company


Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒  No ☐

As of November 13, 2020, 30,000,000 shares of Class A common stock, $0.0001 par value, and 7,500,000 shares of Class B common stock, $0.0001 par value, were issued and outstanding.



CHP MERGER CORP.
Quarterly Report on Form 10-Q

TABLE OF CONTENTS

   
Page
     
PART 1 – FINANCIAL INFORMATION
 
     
Item 1.
1
     
 
1
     
 
2
     
 
3
     
 
4
     
 
5
     
Item 2.
14
     
Item 3.
17
     
Item 4.
17
     
PART II – OTHER INFORMATION
 
     
Item 1.
17
     
Item 1A.
17
     
Item 2.
18
     
Item 3.
18
     
Item 4.
18
     
Item 5.
18
     
Item 6.
18
     
20

PART 1 – FINANCIAL INFORMATION

ITEM 1.
CONDENSED FINANCIAL STATEMENTS

CHP MERGER CORP.
CONDENSED BALANCE SHEETS

   
September 30,
2020
   
December 31,
2019
 
   
(unaudited)
       
ASSETS
           
Current assets
           
Cash
 
$
784,043
   
$
1,301,607
 
Prepaid expenses and other current assets
   
30,900
     
103,344
 
Total Current Assets
   
814,943
     
1,404,951
 
                 
Cash and marketable securities held in trust account
   
302,259,708
     
300,427,494
 
Total Assets
 
$
303,074,651
   
$
301,832,445
 
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities
               
Accounts payable and accrued expenses
 
$
222,095
   
$
121,753
 
Income taxes payable
   
120,996
     
72,043
 
Total Current Liabilities
   
343,091
     
193,796
 
                 
Deferred underwriting fee payable
   
10,500,000
     
10,500,000
 
Total Liabilities
   
10,843,091
     
10,693,796
 
                 
Commitments and contingencies
               
                 
Class A Common stock subject to possible redemption, 28,723,155 and 28,613,864 shares at $10.00 per share at September 30, 2020 and December 31, 2019, respectively
   
287,231,550
     
286,138,640
 
                 
Stockholders’ Equity
               
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
   
     
 
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 1,276,845 and 1,386,136 shares issued and outstanding (excluding 28,723,155 and 28,613,864 shares subject to possible redemption) at September 30, 2020 and December 31, 2019, respectively
   
128
     
139
 
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,500,000 shares issued and outstanding at September 30, 2020 and December 31, 2019
   
750
     
750
 
Additional paid-in capital
   
3,721,710
     
4,814,609
 
Retained earnings
   
1,277,422
     
184,511
 
Total Stockholders’ Equity
   
5,000,010
     
5,000,009
 
Total Liabilities and Stockholders’ Equity
 
$
303,074,651
   
$
301,832,445
 

The accompanying notes are an integral part of the unaudited condensed financial statements.

CHP MERGER CORP.
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
   
For the Period from July 31, 2019 (Inception) Through
September 30,
 
   
2020
   
2020
   
2019
 
General and administrative expenses
 
$
140,833
   
$
452,740
   
$
1,445
 
Loss from operations
   
(140,833
)
   
(452,740
)
   
(1,445
)
                         
Other income:
                       
Interest earned on marketable securities held in trust account
   
89,159
     
1,916,647
     
 
                         
(Loss) income before provision for income taxes
   
(51,674
)
   
1,463,907
     
(1,445
)
Provision for income taxes
   
(8,224
)
   
(370,996
)
   
 
Net (loss) income
 
$
(59,898
)
 
$
1,092,911
   
$
(1,445
)
                         
Weighted average shares outstanding of Class A redeemable common stock
   
30,000,000
     
30,000,000
     
 
Basic and diluted net income per share, Class A redeemable common stock
 
$
0.00
   
$
0.05
   
$
0.00
 
                         
Weighted average shares outstanding of Class B non-redeemable common stock(1)
   
7,500,000
     
7,500,000
     
6,875,000
 
Basic and diluted net loss per share, Class B non-redeemable common stock
 
$
(0.01
)
 
$
(0.04
)
 
$
(0.00
)

(1)
For the period from July 31, 2019 (inception) through September 30, 2019, excluded an aggregate of up to 406,250 shares subject to forfeiture if the over-allotment option was not exercised in full or in party by the underwriters. On November 21, 2019, the Company effected a stock dividend of 718,750 shares with respect to its Class B common stock (see Note 8).
 
The accompanying notes are an integral part of the unaudited condensed financial statements.

CHP MERGER CORP.
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(Unaudited)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2020

   
Class A
Common Stock
   
Class B
Common Stock
   
Additional
Paid-in
   
Retained
   
Total
Stockholders’
 
   
Shares
   
Amount
   
Shares
   
Amount
   
Capital
   
Earnings
   
Equity
 
Balance – January 1, 2020
   
1,386,136
   
$
139
     
7,500,000
   
$
750
   
$
4,814,609
   
$
184,511
   
$
5,000,009
 
                                                         
Change in value of Class A common stock subject to possible redemption
   
(75,195
)
   
(8
)
   
     
     
(751,942
)
   
     
(751,950
)
                                                         
Net income
   
     
     
     
     
     
751,949
     
751,949
 
                                                         
Balance – March 31, 2020
   
1,310,941
     
131
     
7,500,000
     
750
     
4,062,667
     
936,460
     
5,000,008
 
                                                         
Change in value of Class A common stock subject to possible redemption
   
(40,086
)
   
(4
)
   
     
     
(400,856
)
   
     
(400,860
)
                                                         
Net income
   
     
     
     
     
     
400,860
     
400,860
 
                                                         
Balance – June 30, 2020
   
1,270,855
     
127
     
7,500,000
     
750
     
3,661,811
     
1,337,320
     
5,000,008
 
                                                         
Change in value of Class A common stock subject to possible redemption
   
5,990
     
1
     
     
     
59,899
     
     
59,900
 
                                                         
Net loss
   
     
     
     
     
     
(59,898
)
   
(59,898
)
                                                         
Balance – September 30, 2020
   
1,276,845
   
$
128
     
7,500,000
   
$
750
   
$
3,721,710
   
$
1,277,422
   
$
5,000,010
 

FOR THE PERIOD FROM JULY 31, 2019 (INCEPTION) THROUGH SEPTEMBER 30, 2019

   
Class B
Common Stock
   
Additional
Paid-in
   
Accumulated
   
Total
Stockholder's
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
Equity
 
Balance – July 31, 2019 (inception)
   
   
$
   
$
   
$
   
$
 
                                         
Issuance of Class B common stock to Sponsor (1)
   
7,906,250
     
791
     
24,209
     
     
25,000
 
                                         
Net loss
   
     
     
     
(1,445
)
   
(1,445
)
                                         
Balance – September 30, 2019
   
7,906,250
   
$
791
   
$
24,209
   
$
(1,445
)
 
$
23,555
 

(1)
Includes 1,031,250 shares that were subject to forfeiture to the extent the over-allotment option was not exercised in full or in part by the underwriters. On November 21, 2019, the Company effected a stock dividend of 718,750 shares with respect to its Class B common stock (see Note 8).

The accompanying notes are an integral part of the unaudited condensed financial statements.

CHP MERGER CORP.
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)

   
Nine Months Ended
September 30,
   
For the
Period from
July 31,
2019
(Inception)
Through September 30,
 
   
2020
   
2019
 
Cash Flows from Operating Activities:
           
Net income (loss)
 
$
1,092,911
   
$
(1,445
)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
               
Interest earned on marketable securities held in trust account
   
(1,916,647
)
   
 
Changes in operating assets and liabilities:
               
Prepaid expenses and other current assets
   
72,444
     
 
Accounts payable and accrued expenses
   
100,342
     
1,445
 
Income taxes payable
   
48,953
     
 
Net cash used in operating activities
   
(601,997
)
   
 
                 
Cash Flows from Investing Activities:
               
Cash withdrawn for payment of franchise taxes
   
84,433
     
 
Net cash provided by investing activities
   
84,433
     
 
                 
Cash Flows from Financing Activities:
               
Proceeds from issuance of Class B common stock to Sponsor
   
     
25,000
 
Proceeds from promissory note - related party
   
     
43,625
 
Payment of offering costs
   
     
(43,625
)
Net cash provided by financing activities
   
     
25,000
 
                 
Net Change in Cash
   
(517,564
)
   
25,000
 
Cash – Beginning of period
   
1,301,607
     
 
Cash – End of period
 
$
784,043
   
$
25,000
 
Supplemental information:
               
Cash paid for income taxes
  $
322,043
    $
 
                 
Non-Cash financing activities:
               
Change in value of Class A common stock subject to possible redemption
 
$
1,092,910
   
$
 
Deferred offering costs included in accrued offering costs
 
$
   
$
280,450
 

The accompanying notes are an integral part of the unaudited condensed financial statements.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

NOTE 1.
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

CHP Merger Corp. (the “Company”) was incorporated in Delaware on July 31, 2019. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

All activity through September 30, 2020 relates to the Company’s formation, the initial public offering (“initial public offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the initial public offering.

The registration statement for the Company’s initial public offering was declared effective on November 21, 2019. On November 26, 2019, the Company consummated the initial public offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “public shares”), which included the partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 3.

Simultaneously with the closing of the initial public offering, the Company consummated the sale of 8,000,000 warrants (the “Private placement warrants”) at a price of $1.00 per Private placement warrant in a private placement to CHP Acquisition Holdings, LLC (the “Sponsor”), generating gross proceeds of $8,000,000, which is described in Note 4.

Transaction costs amounted to $17,070,862, consisting of $6,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees and $570,862 of other offering costs. As of September 30, 2020, cash of $784,043 was held outside of the trust account and is available for working capital purposes.

Following the closing of the initial public offering on November 26, 2019, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the initial public offering and the sale of the Private placement warrants was placed in a trust account (the “trust account”) which will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination; (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”) (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination by November 26, 2021 or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity; and (iii) the distribution of the trust account, as described below.

Substantially all of the net proceeds of the initial public offering and the sale of the Private placement warrants, are intended to be applied generally toward consummating a Business Combination, and the Company’ management has broad discretion to identify targets for such a potential Business Combination and over the specific application of the funds held in the trust account if and when such funds are properly released from the trust account. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the trust account (excluding the deferred underwriting commissions and taxes payable on income earned on the trust account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

The Company will provide its holders of the outstanding public shares (the “public stockholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the trust account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the trust account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, our Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any public shares purchased during or after the initial public offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all.

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the public shares, without the prior consent of the Company.

Our Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and public shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its public shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their public shares in conjunction with any such amendment.

The Company will have until November 26, 2021 or such later date as a result of a stockholder vote to amend the Amendment and Restarted Certificate of Incorporation, to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

Our Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if our Sponsor acquires public shares in or after the initial public offering, such public shares will be entitled to liquidating distributions from the trust account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the trust account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the trust account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the initial public offering price per Unit ($10.00).

In order to protect the amounts held in the trust account, our Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes (less up to $100,000 of interest to pay dissolution expenses), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under the Company’s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that our Sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the trust account.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

NOTE 2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the SEC on March 23, 2020, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2019 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The interim results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2020 and December 31, 2019.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, the 28,723,155 and 28,613,864 shares of Class A common stock subject to possible redemption, respectively, is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

Offering Costs

Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the initial public offering that are directly related to the initial public offering. Offering costs amounting to $17,070,862 were charged to stockholders’ equity upon the completion of the initial public offering.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020 and December 31, 2019, the Company had a deferred tax asset of approximately $82,000 and $18,000, respectively, which had a full valuation allowance recorded against it of approximately $82,000 and $18,000, respectively.

The Company’s currently taxable income primarily consists of interest income on the trust account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded income tax expense of approximately $8,000 and $371,000, respectively, primarily related to interest income earned on the trust account. The Company’s effective tax rate of (16%) and 25% for the three and nine months ended September 30, 2020, respectively, differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Net Income (Loss) per Common Share

Net income (loss) per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in the initial public offering and private placement to purchase 23,000,000 shares of Class A common stock in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

The Company’s statement of operations includes a presentation of income per share for common shares subject to possible redemption in a manner similar to the two-class method of income per share. Net income per common share, basic and diluted, for Class A redeemable common stock is calculated by dividing the interest income earned on the trust account of $89,159 and $1,916,647 for the three and nine months ended September 30, 2020, respectively (net of applicable franchise and income taxes of approximately $58,000 and $521,000 for the three and nine months ended September 30, 2020, respectively), by the weighted average number of Class A redeemable common stock for the periods. Net loss per common share, basic and diluted, for Class B non-redeemable common stock is calculated by dividing the net loss, less income attributable to Class A redeemable common stock of approximately $31,000 and $1,396,000 for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class B non-redeemable common stock outstanding for the periods. Class B non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the trust account.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 30, 2020 and December 31, 2019, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

NOTE 3.
PUBLIC OFFERING

Pursuant to the initial public offering, the Company sold 30,000,000 Units at a price of $10.00 per Unit, which included the partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000 Units. Each Unit consists of one share of common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

NOTE 4.
PRIVATE PLACEMENT

Simultaneously with the closing of the initial public offering, our Sponsor purchased an aggregate of 8,000,000 Private placement warrants at a purchase price of $1.00 per Private placement warrant for an aggregate purchase price of $8,000,000. Each Private placement warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds from the Private placement warrants was added to the proceeds from the initial public offering held in the trust account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private placement warrants held in the trust account will be used to fund the redemption of the public shares (subject to the requirements of applicable law), and the Private placement warrants will expire worthless.

NOTE 5.
RELATED PARTY TRANSACTIONS

Founder Shares

In August 2019, our Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate price of $25,000. In October 2019, our Sponsor transferred 25,000 Founder Shares to each of the Company’s directors, for a total of 75,000 Founder Shares transferred. On November 21, 2019, the Company effected a stock dividend of 718,750 shares with respect to its Class B common stock, resulting in our Sponsor holding an aggregate of 7,906,250 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the stock dividend. The Founder Shares will automatically convert into shares of Class A common stock at the time of a Business Combination, or earlier at the option of the holders, on a one-for-one basis, subject to certain adjustments, as described in Note 7.

The Founder Shares included an aggregate of up to 1,031,250 shares subject to forfeiture by our Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent approximately 20% of the Company’s issued and outstanding shares after the initial public offering (assuming our Sponsor did not purchase any public shares in the initial public offering). In connection with the underwriters’ partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 406,250 Founder Shares were forfeited and 625,000 Founder Shares are no longer subject to forfeiture. As a result, at December 31, 2019, there are 7,500,000 Founder Shares outstanding.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

Our Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

Promissory Note – Related Party

On August 7, 2019, our Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of January 31, 2020 or the consummation of the initial public offering. The $85,943 borrowed under the Promissory Note was repaid on November 27, 2019.

Related Party Loans

In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor, an affiliate of our Sponsor or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the trust account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the trust account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the trust account to repay the Working Capital Loans but no proceeds held in the trust account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private placement warrants. As of September 30, 2020 and December 31, 2019, no Working Capital Loans were outstanding.

Administrative Support Agreement

The Company entered into an agreement whereby, commencing on November 21, 2019 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of our Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the three and nine months ended September 30, 2020, the Company incurred $30,000 and $97,000 in fees for these services, respectively. As of September 30, 2020 and December 31, 2019, $80,000 and $13,000 are included in accounts payable and accrued expenses, respectively, in the accompanying condensed balance sheets.

NOTE 6.
COMMITMENTS AND CONTINGENCIES

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Registration Rights

Pursuant to a registration rights agreement entered into on November 21, 2019, the holders of the Founder Shares, Private placement warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private placement warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the initial public offering to purchase up to 4,125,000 additional Units to cover over-allotments, if any, at the initial public offering price less the underwriting discounts and commissions. In connection with the closing of the initial public offering on November 26, 2019, the underwriters partially exercised their over-allotment option to purchase an additional 2,500,000 Units at $10.00 per Unit and forfeited the option to exercise the remaining 1,625,000 Units.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $6,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate. The deferred fee will be forfeited by the underwriters in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.

NOTE 7.
STOCKHOLDERS’ EQUITY

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2020 and December 31, 2019, there were no shares of preferred stock issued or outstanding.

Class A Common Stock — The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, 2020 and December 31, 2019, there were 1,276,845 and 1,386,136 shares of Class A common stock issued or outstanding, excluding 28,723,155 and 28,613,864 shares of Class A common stock subject to possible redemption, respectively.

Class B Common Stock — The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. At September 30, 2020 and December 31, 2019, there were 7,500,000 shares of common stock issued and outstanding.

Only holders of Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the initial public offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the initial public offering, plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination and any Private placement warrants issued to our Sponsor of the Company’s officers or directors. Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 12 months from the closing of the initial public offering and (b) 30 days after the completion of a Business Combination.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants.

The Company will use its best efforts to cause the same to become effective within 60 business days following a Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

Redemption of warrants for cash. Once the warrants become exercisable, the Company may call the warrants for redemption:


in whole and not in part;

at a price of $0.01 per warrant;

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities as described below) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. As a result, the Company may redeem the warrants as set forth above even if the holders are otherwise unable to exercise the warrants.

Redemption of warrants for Class A common stock. Commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants:


in whole and not in part;

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares, based on the redemption date and the fair market value of the Class A common stock;

if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;

if, and only if, the Private placement warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and

if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock (or a security other than the Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in the Business Combination) issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.

If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the trust account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the trust account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and, in the case of any such issuance to our Sponsor or its affiliates, without taking into account any Founder Shares held by our Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the Newly Issued Price.

The Private placement warrants are identical to the Public Warrants underlying the Units sold in the initial public offering, except that the Private placement warrants and the shares of common stock issuable upon the exercise of the Private placement warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, and will be entitled to certain registration rights (see Note 6). Additionally, the Private placement warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees (except for a number of shares of Class A common stock as described above under Redemption of warrants for Class A common stock). If the Private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the Private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

CHP MERGER CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(Unaudited)

NOTE 8.
FAIR VALUE MEASUREMENTS

The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts.

At September 30, 2020, assets held in the trust account were comprised of $1,001,114 in money market funds, which are invested in U.S. Treasury Securities, and $301,258,594 in U.S. Treasury Bills. During the nine months ended September 30, 2020, the Company withdrew $84,433 of interest income from the trust account to pay its franchise taxes.

At December 31, 2019, assets held in the trust account were comprised of $1,000,905 in money market funds, which are invested in U.S. Treasury Securities, and $299,426,589 in U.S. Treasury Bills. During the period ended December 31, 2019, the Company has not withdrawn any interest income from the trust account to pay its franchise and income taxes.

The gross holding losses and fair value of held-to-maturity securities at September 30, 2020 and December 31, 2019 are as follows:

 

Held-To-Maturity
 
Amortized
Cost
   
Gross
Holding
Gain (Loss)
   
Fair Value
 
September 30, 2020
U.S. Treasury Securities (Mature on 11/19/2020)
 
$
301,258,594
   
$
11,496
   
$
301,270,090
 
                           
December 31, 2019
U.S. Treasury Securities (Mature on 5/21/2020)
 
$
299,426,589
   
$
(9,722
)
 
$
299,416,867
 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2:
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3:
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

NOTE 9.
SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to CHP Merger Corp. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to CHP Acquisition Holdings, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements other than statements of historical fact included in this Quarterly Report including statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ending December 31, 2019 filed with the SEC on March 23, 2020. The Company’s filings pursuant to the Securities Act and Exchange Act can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company formed under the laws of the State of Delaware on July 31, 2019 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more target businesses. We intend to effectuate our Business Combination using cash from the proceeds of our initial public offering and the sale of the Private placement warrants that occurred simultaneously with the completion of our initial public offering, our capital stock, debt or a combination of cash, stock and debt.

The issuance of additional shares in connection with an initial Business Combination to the owners of the target or other investors:


may significantly dilute the equity interest of investors, which dilution would increase if the anti-dilution provisions in the founder shares resulted in the issuance of shares of Class A common stock on a greater than one-to-one basis upon conversion of the founder shares;


may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;


could cause a change in control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;


may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and


may adversely affect prevailing market prices for our Units, Class A common stock and/or warrants.

Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:


default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;


acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;


our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;


our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;


our inability to pay dividends on our common stock;


using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;


limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;


increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and


limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities through September 30, 2020 were organizational activities, those necessary to prepare for the initial public offering, described below, and identifying a target company for our initial Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the trust account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing our initial Business Combination.

For the three months ended September 30, 2020, we had a net loss of $59,898, which consists of operating costs of $140,833 and a provision for income taxes of $8,224, offset by interest income on marketable securities held in the trust account of $89,159.

For the nine months ended September 30, 2020, we had a net income of $1,092,911, which consists of interest income on marketable securities held in the trust account of $1,916,647, offset by operating costs of $452,740 and a provision for income taxes of $370,996.

For the period from July 31, 2019 (inception) through September 30, 2019, we had net loss $1,445, which consisted of formation and operating costs.

Liquidity and Capital Resources

On November 26, 2019, we consummated the initial public offering of 30,000,000 Units, which included the partial exercise by the underwriters of the over-allotment option to purchase an additional 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $300,000,000. Simultaneously with the closing of the initial public offering, we consummated the sale of 8,000,000 Private placement warrants to our Sponsor at a price of $1.00 per warrant, generating gross proceeds of $8,000,000.

Following the initial public offering, the exercise of the over-allotment option and the sale of the Private placement warrants, a total of $300,000,000 was placed in the trust account. We incurred $17,070,862 in transaction costs, including $6,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees and $570,862 of other offering costs.

For the nine months ended September 30, 2020, cash used in operating activities was $601,997. Net income of $1,092,911 was offset by interest earned on marketable securities held in the trust account of $1,916,647 and changes in operating assets and liabilities, which provided $221,739 of cash from operating activities.

As of September 30, 2020, we had cash and marketable securities held in the trust account of $302,259,708. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less taxes payable and deferred underwriting commissions) to complete our initial Business Combination. We may withdraw interest to pay taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. During the nine months ended September 30, 2020, we withdrew $84,433 of interest income from the trust account to pay our franchise taxes.

As of September 30, 2020, we had $784,043 of cash held outside of the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants identical to the Private placement warrants, at a price of $1.00 per warrant at the option of the lender.

Off-balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2020. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of our Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative support to the Company. We began incurring these fees on November 21, 2019 and will continue to incur these fees monthly until the earlier of the completion of our initial Business Combination and the Company’s liquidation.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate. The deferred fee will be forfeited by the underwriters solely in the event that we fail to complete our initial Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our condensed balance sheets.

Net Income (Loss) Per Common Share

We apply the two-class method in calculating earnings per share. Net income per common share, basic and diluted for Class A redeemable common stock is calculated by dividing the interest income earned on the trust account, net of applicable franchise and income taxes, by the weighted average number of Class A redeemable common stock outstanding for the period. Net loss per common share, basic and diluted for Class B non-redeemable common stock is calculated by dividing the net income, less income attributable to Class A redeemable common stock, by the weighted average number of Class B non-redeemable common stock outstanding for the period presented.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As of September 30, 2020, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds received into the trust account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 180 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

ITEM 4.
CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2020. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.
Changes in Internal Control Over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1.
LEGAL PROCEEDINGS.

None.

ITEM 1A.
RISK FACTORS.

The information to be reported under this item is not required for smaller reporting companies.

ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On November 26, 2019, we consummated our Initial Public Offering of 30,000,000 Units. On November 26, 2019, in connection with underwriters’ election to partially exercise their over-allotment option, we sold an additional 2,500,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $300,000,000. J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC acted as the book running managers of the offering. The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-234413 and 333-234814). The SEC declared the registration statement effective on November 21, 2019.

Simultaneously with the consummation of the Initial Public Offering and the partial exercise of the over-allotment option, we consummated a private placement of 8,000,000 Private placement warrants to our Sponsor at a price of $1.00 per Private placement warrant, generating total proceeds of $8,000,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The Private placement warrants are the same as the warrants underlying the Units sold in the Initial Public Offering, except that Private placement warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private placement warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees.

Of the gross proceeds received from the Initial Public Offering, the partial exercise of the over-allotment option and the Private placement warrants, $300,000,000 was placed in the trust account.

We paid a total of $6,000,000 underwriting discounts and commissions and $570,862 for other costs and expenses related to the initial public offering. In addition, the underwriters agreed to defer $10,500,000 in underwriting discounts and commissions.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.

ITEM 3.
DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.
MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5.
OTHER INFORMATION.

None.

ITEM 6.
EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

No.

Description of Exhibit

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*

XBRL Instance Document
101.CAL*

XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*

XBRL Taxonomy Extension Schema Document
101.DEF*

XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*

XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*

XBRL Taxonomy Extension Presentation Linkbase Document

*
Filed herewith.
**
Furnished.

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


CHP MERGER CORP.



Date: November 13, 2020

/s/ James T. Olsen

Name:
James T. Olsen

Title:
Chief Executive Officer



Date: November 13, 2020

/s/ Benson Jose

Name:
Benson Jose

Title:
Chief Financial Officer


20

EX-31.1 2 brhc10016734_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATIONS

I, James T. Olsen, certify that:


1.
I have reviewed this Quarterly Report on Form 10-Q of CHP Merger Corp.;


2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:


a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)
(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);


c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2020
By:
/s/ James T. Olsen


James T. Olsen


Chief Executive Officer



EX-31.2 3 brhc10016734_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATIONS

I, Benson Jose, certify that:


1.
I have reviewed this Quarterly Report on Form 10-Q of CHP Merger Corp.;


2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:


a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)
(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);


c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2020
By:
/s/ Benson Jose


Benson Jose


Chief Financial Officer



EX-32.1 4 brhc10016734_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADDED BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CHP Merger Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, James T. Olsen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:


1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.
To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 13, 2020
By:
/s/ James T. Olsen


James T. Olsen


Chief Executive Officer



EX-32.2 5 brhc10016734_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADDED BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CHP Merger Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, Benson Jose, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:


1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.
To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 13, 2020
By:
/s/ Benson Jose


Benson Jose


Chief Financial Officer



EX-101.INS 6 chpmu-20200930.xml XBRL INSTANCE DOCUMENT 0001785041 2020-01-01 2020-09-30 0001785041 us-gaap:CommonClassAMember 2020-11-13 0001785041 us-gaap:CommonClassBMember 2020-11-13 0001785041 2020-09-30 0001785041 2019-12-31 0001785041 us-gaap:CommonClassBMember 2019-12-31 0001785041 us-gaap:CommonClassBMember 2020-09-30 0001785041 us-gaap:CommonClassAMember 2019-12-31 0001785041 us-gaap:CommonClassAMember 2020-09-30 0001785041 2020-07-01 2020-09-30 0001785041 2019-07-31 2019-09-30 0001785041 us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001785041 us-gaap:CommonClassBMember 2020-01-01 2020-09-30 0001785041 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001785041 us-gaap:CommonClassAMember 2019-07-31 2019-09-30 0001785041 us-gaap:CommonClassBMember 2020-07-01 2020-09-30 0001785041 us-gaap:CommonClassBMember 2019-07-31 2019-09-30 0001785041 us-gaap:CommonClassBMember us-gaap:InvestorMember 2019-07-31 2019-09-30 0001785041 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-12-31 0001785041 us-gaap:RetainedEarningsMember 2019-07-30 0001785041 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2019-12-31 0001785041 2019-07-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001785041 us-gaap:AdditionalPaidInCapitalMember 2019-07-30 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2019-07-30 0001785041 us-gaap:RetainedEarningsMember 2019-12-31 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-07-01 2020-09-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001785041 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001785041 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001785041 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001785041 2020-01-01 2020-03-31 0001785041 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001785041 2020-04-01 2020-06-30 0001785041 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001785041 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2019-07-31 2019-09-30 0001785041 us-gaap:RetainedEarningsMember 2019-07-31 2019-09-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2019-07-31 2019-09-30 0001785041 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001785041 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001785041 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-09-30 0001785041 us-gaap:RetainedEarningsMember 2019-09-30 0001785041 2019-09-30 0001785041 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-06-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001785041 2020-06-30 0001785041 2020-03-31 0001785041 us-gaap:RetainedEarningsMember 2020-06-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2019-09-30 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-06-30 0001785041 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-31 0001785041 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-09-30 0001785041 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001785041 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-03-31 0001785041 us-gaap:RetainedEarningsMember 2020-03-31 0001785041 us-gaap:RetainedEarningsMember 2020-09-30 0001785041 us-gaap:InvestorMember us-gaap:CommonClassBMember 2019-09-30 0001785041 us-gaap:InvestorMember us-gaap:CommonClassBMember 2019-11-21 2019-11-21 0001785041 us-gaap:IPOMember chpmu:PublicSharesMember 2019-11-26 2019-11-26 0001785041 us-gaap:OverAllotmentOptionMember chpmu:PublicSharesMember 2019-11-26 2019-11-26 0001785041 chpmu:PrivatePlacementWarrantMember 2019-11-26 0001785041 us-gaap:OverAllotmentOptionMember chpmu:PublicSharesMember 2019-11-26 0001785041 us-gaap:IPOMember chpmu:PublicSharesMember 2019-11-26 0001785041 2019-11-26 2019-11-26 0001785041 chpmu:PrivatePlacementWarrantMember 2019-11-26 2019-11-26 0001785041 2019-11-26 0001785041 us-gaap:IPOMember 2019-11-26 2019-11-26 0001785041 srt:MaximumMember 2019-11-26 0001785041 us-gaap:IPOMember 2019-11-26 0001785041 chpmu:PublicWarrantMember us-gaap:IPOMember 2019-11-26 0001785041 chpmu:FounderSharesMember chpmu:Director2Member us-gaap:CommonClassBMember 2019-10-01 2019-10-31 0001785041 srt:DirectorMember chpmu:FounderSharesMember us-gaap:CommonClassBMember 2019-10-01 2019-10-31 0001785041 us-gaap:CommonClassBMember chpmu:Director3Member chpmu:FounderSharesMember 2019-10-01 2019-10-31 0001785041 chpmu:FounderSharesMember us-gaap:CommonClassBMember chpmu:Director1Member 2019-10-01 2019-10-31 0001785041 us-gaap:CommonClassBMember chpmu:FounderSharesMember us-gaap:InvestorMember 2019-11-21 2019-11-21 0001785041 us-gaap:CommonClassBMember us-gaap:InvestorMember chpmu:FounderSharesMember 2019-08-01 2019-08-31 0001785041 chpmu:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001785041 chpmu:FounderSharesMember srt:MaximumMember us-gaap:CommonClassBMember us-gaap:InvestorMember 2019-11-21 0001785041 chpmu:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2019-11-21 0001785041 chpmu:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2019-07-31 2019-12-31 0001785041 chpmu:FounderSharesMember us-gaap:CommonClassBMember us-gaap:InvestorMember 2019-12-31 0001785041 srt:MinimumMember chpmu:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2020-09-30 0001785041 chpmu:FounderSharesMember us-gaap:InvestorMember srt:MinimumMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001785041 srt:MaximumMember chpmu:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember chpmu:WorkingCapitalLoansThatMayBeConvertibleIntoWarrantsMember 2020-01-01 2020-09-30 0001785041 srt:MaximumMember chpmu:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember us-gaap:InvestorMember 2019-08-07 2019-08-07 0001785041 us-gaap:InvestorMember chpmu:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember 2019-11-27 2019-11-27 0001785041 chpmu:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember chpmu:WorkingCapitalLoansThatMayBeConvertibleIntoWarrantsMember 2020-09-30 0001785041 chpmu:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember chpmu:WorkingCapitalLoansThatMayBeConvertibleIntoWarrantsMember 2019-12-31 0001785041 chpmu:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember us-gaap:InvestorMember 2019-11-21 2019-11-21 0001785041 chpmu:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember us-gaap:InvestorMember 2020-01-01 2020-09-30 0001785041 us-gaap:InvestorMember chpmu:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember 2020-07-01 2020-09-30 0001785041 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:InvestorMember chpmu:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember 2020-09-30 0001785041 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:InvestorMember chpmu:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember 2019-12-31 0001785041 srt:MaximumMember us-gaap:OverAllotmentOptionMember 2019-11-26 2019-11-26 0001785041 us-gaap:OverAllotmentOptionMember 2019-11-26 2019-11-26 0001785041 us-gaap:OverAllotmentOptionMember 2019-11-26 0001785041 us-gaap:CommonClassAMember 2019-01-01 2019-12-31 0001785041 srt:MinimumMember 2020-01-01 2020-09-30 0001785041 srt:MaximumMember 2020-01-01 2020-09-30 0001785041 us-gaap:CommonClassAMember chpmu:SecondOfferingMember 2020-01-01 2020-09-30 0001785041 us-gaap:CommonClassAMember chpmu:SecondOfferingMember 2020-09-30 0001785041 chpmu:SecondOfferingMember srt:MaximumMember us-gaap:CommonClassAMember 2020-09-30 0001785041 srt:MaximumMember us-gaap:CommonClassAMember 2020-09-30 0001785041 us-gaap:MoneyMarketFundsMember 2019-12-31 0001785041 us-gaap:MoneyMarketFundsMember 2020-09-30 0001785041 us-gaap:USTreasuryBillSecuritiesMember 2020-09-30 0001785041 us-gaap:USTreasuryBillSecuritiesMember 2019-12-31 0001785041 us-gaap:USTreasurySecuritiesMember 2020-09-30 0001785041 us-gaap:USTreasurySecuritiesMember 2019-12-31 0001785041 2019-01-01 2019-12-31 0001785041 us-gaap:USTreasurySecuritiesMember 2020-01-01 2020-09-30 0001785041 us-gaap:USTreasurySecuritiesMember 2019-01-01 2019-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 80000 13000 222095 121753 4814609 3721710 23000000 303074651 301832445 814943 1404951 1000905 1001114 302259708 300427494 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Basis of Presentation</div><div><br /></div><div style="text-align: justify;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</div><div><br /></div><div style="text-align: justify;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the SEC on March 23, 2020, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2019 is derived from the audited financial statements presented in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019. The interim results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 2.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div></td></tr></table><div><br /></div><div style="text-align: justify; font-weight: bold;">Basis of Presentation</div><div><br /></div><div style="text-align: justify;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</div><div><br /></div><div style="text-align: justify;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the SEC on March 23, 2020, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2019 is derived from the audited financial statements presented in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019. The interim results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Emerging Growth Company</div><div><br /></div><div style="text-align: justify;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</div><div><br /></div><div style="text-align: justify;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Use of Estimates</div><div><br /></div><div style="text-align: justify;">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div><div><br /></div><div style="text-align: justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Cash and Cash Equivalents</div><div><br /></div><div style="text-align: justify;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2020 and December 31, 2019.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Common Stock Subject to Possible Redemption</div><div><br /></div><div style="text-align: justify;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, the 28,723,155 and 28,613,864 shares of Class A common stock subject to possible redemption, respectively, is presented as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s condensed balance sheets.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Offering Costs</div><div><br /></div><div style="text-align: justify;">Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the initial public offering that are directly related to the initial public offering. Offering costs amounting to $17,070,862 were charged to stockholders&#8217; equity upon the completion of the initial public offering.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Income Taxes</div><div><br /></div><div style="text-align: justify;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020 and December 31, 2019, the Company had a deferred tax asset of approximately $82,000 and $18,000, respectively, which had a full valuation allowance recorded against it of approximately $82,000 and $18,000, respectively.</div><div><br /></div><div style="text-align: justify;">The Company&#8217;s currently taxable income primarily consists of interest income on the trust account. The Company&#8217;s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded income tax expense of approximately $8,000 and $371,000, respectively, primarily related to interest income earned on the trust account. The Company&#8217;s effective tax rate of (16%) and 25% for the three and nine months ended September 30, 2020, respectively, differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.</div><div><br /></div><div style="text-align: justify;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Net Income (Loss) per Common Share</div><div><br /></div><div style="text-align: justify;">Net income (loss) per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in the initial public offering and private placement to purchase 23,000,000 shares of Class A common stock in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</div><div><br /></div><div style="text-align: justify;">The Company&#8217;s statement of operations includes a presentation of income per share for common shares subject to possible redemption in a manner similar to the two-class method of income per share. Net income per common share, basic and diluted, for Class A redeemable common stock is calculated by dividing the interest income earned on the trust account of $89,159 and $1,916,647 for the three and nine months ended September 30, 2020, respectively (net of applicable franchise and income taxes of approximately $58,000 and $521,000 for the three and nine months ended September 30, 2020, respectively), by the weighted average number of Class A redeemable common stock for the periods. Net loss per common share, basic and diluted, for Class B non-redeemable common stock is calculated by dividing the net loss, less income attributable to Class A redeemable common stock of approximately $31,000 and $1,396,000 for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class B non-redeemable common stock outstanding for the periods. Class B non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the trust account.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Concentration of Credit Risk</div><div><br /></div><div style="text-align: justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 30, 2020 and December 31, 2019, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</div><div><br /></div><div style="text-align: justify; margin-right: 125.8pt; font-weight: bold;">Financial Instruments</div><div><br /></div><div style="text-align: justify;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurement,&#8221; approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.</div><div><br /></div><div style="text-align: justify; margin-right: 125.8pt; font-weight: bold;">Recent Accounting Standards</div><div><br /></div><div style="text-align: justify;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s condensed financial statements.</div></div> -517564 25000 0 1301607 25000 784043 784043 1301607 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Cash and Cash Equivalents</div><div><br /></div><div style="text-align: justify;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2020 and December 31, 2019.</div></div> 0 0 11.50 11.50 1 1 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 6.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">COMMITMENTS AND CONTINGENCIES</div></td></tr></table><div><br /></div><div style="text-align: justify; font-weight: bold;">Risks and Uncertainties</div><div><br /></div><div style="text-align: justify;">Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Registration Rights</div><div><br /></div><div style="text-align: justify;">Pursuant to a registration rights agreement entered into on November 21, 2019, the holders of the Founder Shares, Private placement warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private placement warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders will have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-weight: bold;">Underwriting Agreement</div><div><br /></div><div style="text-align: justify;">The Company granted the underwriters a 45-day option from the date of the initial public offering to purchase up to 4,125,000 additional Units to cover over-allotments, if any, at the initial public offering price less the underwriting discounts and commissions. In connection with the closing of the initial public offering on November 26, 2019, the underwriters partially exercised their over-allotment option to purchase an additional 2,500,000 Units at $10.00 per Unit and forfeited the option to exercise the remaining 1,625,000 Units.</div><div><br /></div><div style="text-align: justify;">The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $6,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate. The deferred fee will be forfeited by the underwriters in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.</div></div> 0.0001 0.0001 0.0001 0.0001 7500000 1276845 1386136 7500000 One vote One vote 20000000 20000000 200000000 200000000 1276845 1386136 7500000 7500000 750 750 139 128 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Concentration of Credit Risk</div><div><br /></div><div style="text-align: justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 30, 2020 and December 31, 2019, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Offering Costs</div><div><br /></div><div style="text-align: justify;">Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the initial public offering that are directly related to the initial public offering. Offering costs amounting to $17,070,862 were charged to stockholders&#8217; equity upon the completion of the initial public offering.</div></div> 17070862 18000 82000 82000 18000 -0.04 0 0 0 -0.01 0.05 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Net Income (Loss) per Common Share</div><div><br /></div><div style="text-align: justify;">Net income (loss) per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in the initial public offering and private placement to purchase 23,000,000 shares of Class A common stock in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.</div><div><br /></div><div style="text-align: justify;">The Company&#8217;s statement of operations includes a presentation of income per share for common shares subject to possible redemption in a manner similar to the two-class method of income per share. Net income per common share, basic and diluted, for Class A redeemable common stock is calculated by dividing the interest income earned on the trust account of $89,159 and $1,916,647 for the three and nine months ended September 30, 2020, respectively (net of applicable franchise and income taxes of approximately $58,000 and $521,000 for the three and nine months ended September 30, 2020, respectively), by the weighted average number of Class A redeemable common stock for the periods. Net loss per common share, basic and diluted, for Class B non-redeemable common stock is calculated by dividing the net loss, less income attributable to Class A redeemable common stock of approximately $31,000 and $1,396,000 for the three and nine months ended September 30, 2020, respectively, by the weighted average number of Class B non-redeemable common stock outstanding for the periods. Class B non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the trust account.</div></div> 0.25 -0.16 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; margin-right: 125.8pt; font-weight: bold;">Financial Instruments</div><div><br /></div><div style="text-align: justify;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurement,&#8221; approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 8.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">FAIR VALUE MEASUREMENTS</div></td></tr></table><div><br /></div><div style="text-align: justify;">The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC 320 &#8220;Investments - Debt and Equity Securities.&#8221; Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts.</div><div><br /></div><div style="text-align: justify;">At September 30, 2020, assets held in the trust account were comprised of $1,001,114 in money market funds, which are invested in U.S. Treasury Securities, and $301,258,594 in U.S. Treasury Bills. During the nine months ended September 30, 2020, the Company withdrew $84,433 of interest income from the trust account to pay its franchise taxes.</div><div><br /></div><div style="text-align: justify;">At December 31, 2019, assets held in the trust account were comprised of $1,000,905 in money market funds, which are invested in U.S. Treasury Securities, and $299,426,589 in U.S. Treasury Bills. During the period ended December 31, 2019, the Company has not withdrawn any interest income from the trust account to pay its franchise and income taxes.</div><div><br /></div><div style="text-align: justify;">The gross holding losses and fair value of held-to-maturity securities at September 30, 2020 and December 31, 2019 are as follows:</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div>&#160;</div><div style="text-align: center; font-weight: bold;"><br /></div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Held-To-Maturity</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Amortized</div><div style="text-align: center; font-weight: bold;">Cost</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Gross</div><div style="text-align: center; font-weight: bold;">Holding</div><div style="text-align: center; font-weight: bold;">Gain (Loss)</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Fair Value</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">September 30, 2020</div></td><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">U.S. Treasury Securities (Mature on 11/19/2020)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>301,258,594</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>11,496</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>301,270,090</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 32%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 32%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">December 31, 2019</div></td><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">U.S. Treasury Securities (Mature on 5/21/2020)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>299,426,589</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>(9,722</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;"><div>)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>299,416,867</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify;">The fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</div><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 72pt; vertical-align: top; align: right;">Level 1:</td><td style="width: auto; vertical-align: top;"><div>Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 72pt; vertical-align: top; align: right;">Level 2:</td><td style="width: auto; vertical-align: top;"><div>Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 72pt; vertical-align: top; align: right;">Level 3:</td><td style="width: auto; vertical-align: top;"><div>Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</div></td></tr></table></div> 140833 452740 1445 301258594 299426589 9722 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify;">The gross holding losses and fair value of held-to-maturity securities at September 30, 2020 and December 31, 2019 are as follows:</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div>&#160;</div><div style="text-align: center; font-weight: bold;"><br /></div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Held-To-Maturity</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Amortized</div><div style="text-align: center; font-weight: bold;">Cost</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Gross</div><div style="text-align: center; font-weight: bold;">Holding</div><div style="text-align: center; font-weight: bold;">Gain (Loss)</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"><div style="text-align: center; font-weight: bold;">Fair Value</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">September 30, 2020</div></td><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">U.S. Treasury Securities (Mature on 11/19/2020)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>301,258,594</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>11,496</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>301,270,090</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 32%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 32%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">December 31, 2019</div></td><td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 3.2pt;">U.S. Treasury Securities (Mature on 5/21/2020)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>299,426,589</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>(9,722</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;"><div>)</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td><td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>$</div></td><td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div>299,416,867</div></td><td colspan="1" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td></tr></table></div> 11496 301270090 299416867 2020-11-19 2020-05-21 -51674 1463907 -1445 370996 8224 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Income Taxes</div><div><br /></div><div style="text-align: justify;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2020 and December 31, 2019, the Company had a deferred tax asset of approximately $82,000 and $18,000, respectively, which had a full valuation allowance recorded against it of approximately $82,000 and $18,000, respectively.</div><div><br /></div><div style="text-align: justify;">The Company&#8217;s currently taxable income primarily consists of interest income on the trust account. The Company&#8217;s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30, 2020, the Company recorded income tax expense of approximately $8,000 and $371,000, respectively, primarily related to interest income earned on the trust account. The Company&#8217;s effective tax rate of (16%) and 25% for the three and nine months ended September 30, 2020, respectively, differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.</div><div><br /></div><div style="text-align: justify;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div></div> 0 322043 48953 0 100342 1445 -72444 0 89159 0 1916647 1916647 89159 301258594 299426589 1001114 1000905 303074651 301832445 10693796 10843091 343091 193796 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 1.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</div></td></tr></table><div><br /></div><div style="text-align: justify;">CHP Merger Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on July 31, 2019. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;).</div><div><br /></div><div style="text-align: justify;">The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</div><div><br /></div><div style="text-align: justify;">All activity through September 30, 2020 relates to the Company&#8217;s formation, the initial public offering (&#8220;initial public offering&#8221;), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the initial public offering.</div><div><br /></div><div style="text-align: justify;">The registration statement for the Company&#8217;s initial public offering was declared effective on November 21, 2019. On November 26, 2019, the Company consummated the initial public offering of 30,000,000 units (the &#8220;Units&#8221; and, with respect to the shares of Class A common stock included in the Units sold, the &#8220;public shares&#8221;), which included the partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 3.</div><div><br /></div><div style="text-align: justify;">Simultaneously with the closing of the initial public offering, the Company consummated the sale of 8,000,000 warrants (the &#8220;Private placement warrants&#8221;) at a price of $1.00 per Private placement warrant in a private placement to CHP Acquisition Holdings, LLC (the &#8220;Sponsor&#8221;), generating gross proceeds of $8,000,000, which is described in Note 4.</div><div><br /></div><div style="text-align: justify;">Transaction costs amounted to $17,070,862, consisting of $6,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees and $570,862 of other offering costs. As of September 30, 2020, cash of $784,043 was held outside of the trust account and is available for working capital purposes.</div><div><br /></div><div style="text-align: justify;">Following the closing of the initial public offering on November 26, 2019, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the initial public offering and the sale of the Private placement warrants was placed in a trust account (the &#8220;trust account&#8221;) which will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination; (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company&#8217;s Amended <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">and Restated Certificate of Incorporation (the &#8220;Amended and Restated Certificate of Incorporation&#8221;) (A) to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with the Company&#8217;s initial Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination by November 26, 2021 or (B) with respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity; and (iii) the distribution of the trust account, as described below.</font></div><div><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"></font></div><div><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><br /></font></div><div><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"></font></div><div style="text-align: justify;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Substantially all of the net proceeds of the initial public offering and the sale of the Private placement warrants, are intended to be applied generally toward consummating a Business Combination, and the Company&#8217; management has broad discretion to identify targets for such a potential Business Combination and over the specific application of the funds held in the trust account if and when such funds are properly released from the trust account. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the trust account (excluding the deferred underwriting commissions and taxes payable on income earned on the trust account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business C</font>ombination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div><div><br /></div><div style="text-align: justify;">The Company will provide its holders of the outstanding public shares (the &#8220;public stockholders&#8221;) with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the trust account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the trust account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants.</div><div><br /></div><div style="text-align: justify;">The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, our Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any public shares purchased during or after the initial public offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or don&#8217;t vote at all.</div><div><br /></div><div style="text-align: justify;">Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the public shares, without the prior consent of the Company.</div><div><br /></div><div style="text-align: justify;">Our Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and public shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with the Company&#8217;s initial Business Combination or to redeem 100% of its public shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders&#8217; rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their public shares in conjunction with any such amendment.</div><div><br /></div><div style="text-align: justify;">The Company will have until November 26, 2021 or such later date as a result of a stockholder vote to amend the Amendment and Restarted&#160;Certificate of Incorporation, to complete a Business Combination (the &#8220;Combination Period&#8221;). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</div><div><br /></div><div style="text-align: justify;">Our Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if our Sponsor acquires public shares in or after the initial public offering, such public shares will be entitled to liquidating distributions from the trust account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the trust account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the trust account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the initial public offering price per Unit ($10.00).</div><div><br /></div><div style="text-align: justify;">In order to protect the amounts held in the trust account, our Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes (less up to $100,000 of interest to pay dissolution expenses), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that our Sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company&#8217;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the trust account.</div></div> -601997 0 -1445 -59898 1092911 0 -59898 0 0 0 751949 0 0 751949 0 -1445 0 0 0 400860 400860 0 31000 1396000 0 84433 0 25000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; margin-right: 125.8pt; font-weight: bold;">Recent Accounting Standards</div><div><br /></div><div><div style="text-align: justify;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s condensed financial statements.</div></div></div> 0 0 -1445 -452740 -140833 43625 0 6000000 0 0 0 0 0 0 0.0001 0.0001 1000000 1000000 30900 103344 0 25000 25000 300000000 8000000 0 43625 1500000 300000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 5.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">RELATED PARTY TRANSACTIONS</div></td></tr></table><div><br /></div><div style="text-align: justify; margin-right: 4.5pt; font-weight: bold;">Founder Shares</div><div><br /></div><div style="text-align: justify;">In August 2019, our Sponsor purchased 7,187,500 shares (the &#8220;Founder Shares&#8221;) of the Company&#8217;s Class B common stock for an aggregate price of $25,000. In October 2019, our Sponsor transferred 25,000 Founder Shares to each of the Company&#8217;s directors, for a total of 75,000 Founder Shares transferred. On November 21, 2019, the Company effected a stock dividend of 718,750 shares with respect to its Class B common stock, resulting in our Sponsor holding an aggregate of 7,906,250 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the stock dividend. The Founder Shares will automatically convert into shares of Class A common stock at the time of a Business Combination, or earlier at the option of the holders, on a one-for-one basis, subject to certain adjustments, as described in Note 7.</div><div><br /></div><div style="text-align: justify;">The Founder Shares included an aggregate of up to 1,031,250 shares subject to forfeiture by our Sponsor to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent approximately 20% of the Company&#8217;s issued and outstanding shares after the initial public offering (assuming our Sponsor did not purchase any public shares in the initial public offering). In connection with the underwriters&#8217; partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 406,250 Founder Shares were forfeited and 625,000 Founder Shares are no longer subject to forfeiture. As a result, at December 31, 2019, there are 7,500,000 Founder Shares outstanding.</div><div><br /></div><div style="text-align: justify;">Our Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.</div><div><br /></div><div style="text-align: justify; margin-right: 18pt; font-weight: bold;">Promissory Note &#8211; Related Party</div><div><br /></div><div style="text-align: justify;">On August 7, 2019, our Sponsor issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of January 31, 2020 or the consummation of the initial public offering. The $85,943 borrowed under the Promissory Note was repaid on November 27, 2019.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Related Party Loans</div><div><br /></div><div style="text-align: justify;">In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor, an affiliate of our Sponsor or certain of the Company&#8217;s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the trust account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the trust account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the trust account to repay the Working Capital Loans but no proceeds held in the trust account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private placement warrants. As of September 30, 2020 and December 31, 2019, no Working Capital Loans were outstanding.</div><div><br /></div><div style="text-align: justify; font-weight: bold;">Administrative Support Agreement</div><div><br /></div><div style="text-align: justify;">The Company entered into an agreement whereby, commencing on November 21, 2019 through the earlier of the Company&#8217;s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of our Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the three and nine months ended September 30, 2020, the Company incurred $30,000 and $97,000 in fees for these services, respectively. As of September 30, 2020 and December 31, 2019, $80,000 and $13,000 are included in accounts payable and accrued expenses, respectively, in the accompanying condensed balance sheets.</div></div> 97000 30000 85943 184511 1277422 12.00 10.00 9.20 18.00 1386136 0 7500000 7906250 1310941 1270855 7500000 1276845 7500000 7500000 625000 7500000 1.00 10.00 10.00 10.00 718750 718750 7906250 25000 75000 25000 25000 7906250 7187500 791 0 24209 25000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 7.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">STOCKHOLDERS&#8217; EQUITY</div></td></tr></table><div><br /></div><div style="text-align: justify;"><font style="font-weight: bold;">Preferred Stock &#8212;</font> The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At September 30, 2020 and December 31, 2019, there were no shares of preferred stock issued or outstanding.</div><div><br /></div><div style="text-align: justify;"><font style="font-weight: bold;">Class A Common Stock &#8212;</font> The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, 2020 and December 31, 2019, there were 1,276,845 and 1,386,136 shares of Class A common stock issued or outstanding, excluding 28,723,155 and 28,613,864 shares of Class A common stock subject to possible redemption, respectively.</div><div><br /></div><div style="text-align: justify;"><font style="font-weight: bold;">Class B Common Stock &#8212;</font> The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. At September 30, 2020 and December 31, 2019, there were 7,500,000 shares of common stock issued and outstanding.</div><div><br /></div><div style="text-align: justify;">Only holders of Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.</div><div><br /></div><div style="text-align: justify;">The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the initial public offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the initial public offering, plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination and any Private placement warrants issued to our Sponsor of the Company&#8217;s officers or directors. Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.</div><div><br /></div><div style="text-align: justify;"><font style="font-weight: bold;">Warrants &#8212;</font> Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 12 months from the closing of the initial public offering and (b) 30 days after the completion of a Business Combination.</div><div><br /></div><div style="text-align: justify;">The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.</div><div><br /></div><div style="text-align: justify;">The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants.</div><div><br /></div><div style="text-align: justify;">The Company will use its best efforts to cause the same to become effective within 60 business days following a Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available.</div><div><br /></div><div style="text-align: justify;"><font style="font-style: italic;">Redemption of warrants for cash</font>. Once the warrants become exercisable, the Company may call the warrants for redemption:</div><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>in whole and not in part;</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>at a price of $0.01 per warrant;</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>upon not less than 30 days&#8217; prior written notice of redemption to each warrant holder; and</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities as described below) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders.</div></td></tr></table><div><br /></div><div style="text-align: justify;">If and when the warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. As a result, the Company may redeem the warrants as set forth above even if the holders are otherwise unable to exercise the warrants.</div><div><br /></div><div style="text-align: justify;"><font style="font-style: italic;">Redemption of warrants for Class A common stock</font>. Commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants:</div><div><br /></div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>in whole and not in part;</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares, based on the redemption date and the fair market value of the Class A common stock;</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>if, and only if, the Private placement warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and</div></td></tr></table><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 18pt;"><br /></td><td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td><td style="width: auto; vertical-align: top;"><div>if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock (or a security other than the Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in the Business Combination) issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.</div></td></tr></table><div><br /></div><div style="text-align: justify;">If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the trust account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the trust account with the respect to such warrants. Accordingly, the warrants may expire worthless.</div><div><br /></div><div style="text-align: justify;">In addition, if the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors, and, in the case of any such issuance to our Sponsor or its affiliates, without taking into account any Founder Shares held by our Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the Newly Issued Price.</div><div><br /></div><div style="text-align: justify;">The Private placement warrants are identical to the Public Warrants underlying the Units sold in the initial public offering, except that the Private placement warrants and the shares of common stock issuable upon the exercise of the Private placement warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, and will be entitled to certain registration rights (see Note 6). Additionally, the Private placement warrants will be exercisable for cash or on a cashless basis, at the holder&#8217;s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees (except for a number of shares of Class A common stock as described above under <font style="font-style: italic;">Redemption of warrants for Class A common stock</font>). If the Private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the Private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</div></div> 5000009 5000010 139 0 750 0 4814609 0 0 184511 128 -1445 23555 127 3721710 4062667 5000008 5000008 1337320 24209 791 750 131 750 3661811 750 936460 1277422 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 9.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">SUBSEQUENT EVENTS</div></td></tr></table><div><br /></div><div style="text-align: justify;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.</div></div> 120996 72043 10.00 10.00 28613864 28723155 287231550 286138640 0 0 0 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Use of Estimates</div><div><br /></div><div style="text-align: justify;">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div><div><br /></div><div style="text-align: justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</div></div> 30000000 7500000 30000000 0 7500000 6875000 false --12-31 2020-09-30 NJ Yes Non-accelerated Filer CHP Merger Corp. 0001785041 30000000 7500000 2020 Q3 10-Q Yes true true false true 1 1 0.2 30000000 2500000 4125000 2500000 P45D 1625000 10500000 0.35 0.20 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-weight: bold;">Common Stock Subject to Possible Redemption</div><div><br /></div><div style="text-align: justify;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, the 28,723,155 and 28,613,864 shares of Class A common stock subject to possible redemption, respectively, is presented as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s condensed balance sheets.</div></div> 521000 58000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 3.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">PUBLIC OFFERING</div></td></tr></table><div><br /></div><div style="text-align: justify;">Pursuant to the initial public offering, the Company sold 30,000,000 Units at a price of $10.00 per Unit, which included the partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000 Units. Each Unit consists of one share of common stock and one-half of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 7).</div></div> 1 0.5 10500000 10500000 0 84433 0 1092910 84433 0 280450 0 0 751942 0 -59900 4 400856 0 -1 751950 -59899 400860 8 0 -5990 75195 40086 1.15 P15D P60D P20D P20D 1.8 P30D P12M P90D P30D P30D P30D 18.00 0.10 0.01 P30D P30D <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTE 4.</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-weight: bold;">PRIVATE PLACEMENT</div></td></tr></table><div><br /></div><div style="text-align: justify;">Simultaneously with the closing of the initial public offering, our Sponsor purchased an aggregate of 8,000,000 Private placement warrants at a purchase price of $1.00 per Private placement warrant for an aggregate purchase price of $8,000,000. Each Private placement warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds from the Private placement warrants was added to the proceeds from the initial public offering held in the trust account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private placement warrants held in the trust account will be used to fund the redemption of the public shares (subject to the requirements of applicable law), and the Private placement warrants will expire worthless.</div></div> 8000000 10000 100000 300000000 10.00 570862 6000000 0.2 1031250 1031250 406250 406250 P150D Includes 1,031,250 shares that were subject to forfeiture to the extent the over-allotment option was not exercised in full or in part by the underwriters. On November 21, 2019, the Company effected a stock dividend of 718,750 shares with respect to its Class B common stock (see Note 8). For the period from July 31, 2019 (inception) through September 30, 2019, excluded aggregate of up to 406,250 shares subject to forfeiture if the over-allotment option was not exercised in full or in party by the underwriters. EX-101.SCH 7 chpmu-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 020100 - Statement - CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030100 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - PUBLIC OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - PRIVATE PLACEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - RELATED PARTY TRANSACTIONS, Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 090502 - Disclosure - RELATED PARTY TRANSACTIONS, Promissory Note, Related Party Loans and Administrative Support Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - STOCKHOLDERS' EQUITY, Preferred Stock and Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 090702 - Disclosure - STOCKHOLDERS' EQUITY, Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 chpmu-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 chpmu-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 chpmu-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Accounts Payable and Accrued Expenses [Member] Amount payable Accounts Payable, Related Parties, Current Accounts payable and accrued expenses Additional Paid-in Capital [Member] Additional paid-in capital Adjustments to reconcile net income (loss) to net cash used in operating activities: Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] ASSETS Assets [Abstract] Total Assets Assets Total Current Assets Assets, Current Assets held in trust Current assets Cash and marketable securities held in trust account Balance Sheet Location [Domain] Balance Sheet Location [Axis] Basis of Presentation SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Net Change in Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash and Cash Equivalents [Abstract] Cash - End of period Cash - Beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash Cash held outside of trust account Cash and Cash Equivalents Cash equivalents Non-Cash financing activities: Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Exercise price of warrant (In dollars per share) Class of Stock [Line Items] Number of securities called by each warrant (in shares) Class of Stock [Domain] Commitments and contingencies COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES Commitments Disclosure [Text Block] Class B Common Stock [Member] Class B Ordinary Shares [Member] Common Stock [Member] Class A Common Stock [Member] Class A Ordinary Shares [Member] Common stock, par value (in dollars per share) Common stock, shares issued (in shares) Voting right per share Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Common stock Common Stock, Value, Issued Concentration of Credit Risk Offering Costs Deferred Charges, Policy [Policy Text Block] Offering costs Transaction costs Deferred Offering Costs Deferred tax assets Valuation allowance Basic and diluted net income (loss) per share (in dollars per share) Net Income (Loss) per Common Share Net Income (Loss) per Common Share [Abstract] Effective tax rate Equity Component [Domain] STOCKHOLDERS' EQUITY [Abstract] Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] FAIR VALUE MEASUREMENTS [Abstract] FAIR VALUE MEASUREMENTS Financial Instrument [Axis] General and administrative expenses Amortized Cost